The development of a COVID-19 ‘DNA and viral vector-based vaccine’ made with 100% domestic technology is well underway.

Although in its preclinical stage, the vaccine, once commercialized, is expected to show superior safety and protection over existing COVID-19 vaccines by Pfizer, Moderna, AstraZeneca as well as vaccines from Russia and China.

Professor Young Bong Kim of Biomedical Science & Engineering at Konkuk University and his team have recently announced positive results from the preclinical study of their Covid-19 vaccine in development. The study used hamsters to assess the immunogenicity, antibody production, seroconversion rates, and increments in geometric mean concentrat